Results 311 to 320 of about 276,476 (390)

Assessing Parkinson's Rest Tremor from the Wrist with Accelerometry and Gyroscope Signals in Patients with Deep Brain Stimulation: An Observational Study. [PDF]

J Clin Med
Keba M, Bachmann M, Lass J, Rätsep T.
europepmc   +1 more source

Adult‐Onset Dystonia‐Parkinsonism: Do Not Forget SERAC1

Movement Disorders Clinical Practice, EarlyView.
Giulia Scacciatella, Costanza Masetti, Vidal Yahya, Mauro Treddenti, Gaia Oggioni, Tommaso Bocci, Laura Campiglio, Manuela Zardoni, Chiara Rosci, Marta Pengo, Chiara Manfredi, Roberto Del Bo, Edoardo Monfrini, Alessio Di Fonzo, Maurizio Inghilleri, Alberto Priori   +15 more
wiley   +1 more source

Predictors of Loneliness in Parkinson's Disease and Craniocervical Dystonia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Loneliness is a state in which an individual feels socially isolated due to deficiencies in the quantity or quality of social relationships and interaction. To date very little is known about loneliness in Parkinson's disease (PD) and focal/segmental craniocervical dystonia (FSCD).
Suzette Shahmoon, Dejan Georgiev, Paul Jarman, Kailash Bhatia, Patricia Limousin, Marjan Jahanshahi   +5 more
wiley   +1 more source

Corrigendum to "Tremor After Solid Organ Transplantation: Results From the TransplantLines Biobank and Cohort Study". [PDF]

Eur J Neurol
europepmc   +1 more source

Effect of Orthostatic Tremor on Quality of Life - a Cohort Study. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Babeliowsky WA, Swinnen B, Hoogland J, de Bie RMA, van Rootselaar AF.   +4 more
europepmc   +1 more source

Long‐Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN‐Open‐Label Study

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister, Atul T. Patel, Marta Banach, Aaron Ellenbogen, Jaroslaw Slawek, Sebastian Paus, Hyder A. Jinnah, Virgilio Evidente, Todd M. Gross, Rashid Kazerooni, Conor J. Gallagher, David A. Hollander   +11 more
wiley   +1 more source

Oscillatory Coupling Between Thalamus, Cerebellum, and Motor Cortex in Essential Tremor. [PDF]

Mov Disord
Steina A, Sure S, Butz M, Vesper J, Schnitzler A, Hirschmann J.   +5 more
europepmc   +1 more source

Deep Brain Stimulation Improves Symptoms in an Individual with Alpha‐Synuclein‐Gene‐Associated Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abigail Braun, Dion Basson, Shahida Moosa, Jonathan Carr, Soraya Bardien, Riaan van Coller   +5 more
wiley   +1 more source

Myoclonic Dystonia: A Common Phenomenology in the Pleomorphic Movements of Angelman Syndrome

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Angelman syndrome (AS) is a neurodevelopmental disorder characterized by developmental delay, intellectual disability, a sociable demeanor, and abnormal movements. People with AS often exhibit multiple types of abnormal movements, including nonepileptic myoclonus, tremor, and dystonia, which hamper attempts to identify phenomenology
Robert P. Carson, Heather Riordan, Brittany Short, Thomas Davis, John Fang, Andrew Giritharan, David A. Isaacs, Joanna Blackburn, Bhooma Aravamuthan   +8 more
wiley   +1 more source

Data-Driven Subtypes of Parkinson Disease Based on Dopamine Responsiveness. [PDF]

CNS Neurosci Ther
Wang JY, Zeng GL, Tang RT, Luo HT, Song YL, Zhou YY, Huang JF, Zhu SG, Zhang DL, Liu DN, Liu RP, Huang SS, Yuan CX, Zhu JH, Zhang X.   +14 more
europepmc   +1 more source